Sputum analysis: Non-invasive early lung cancer detection

Journal of Cellular Physiology

Volumn 228, Issue 5, 2013, Pages 945-951

  D'Urso, Vittorio ^a   Doneddu, Valentina ^b   Marchesi, Irene ^b   Collodoro, Angelo ^c   Pirina, Pietro ^b   Giordano, Antonio ^c,d   Bagella, Luigi ^b,d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MICRORNA; PROTEIN P53;

ARTICLE; BRONCHOSCOPY; CANCER SCREENING; CELL SELECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY CANCER; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INVASIVE PROCEDURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THORAX RADIOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPUTUM; SURVIVAL RATE;

EID: 84873863960     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24263     Document Type: Article

References (91)

1. Barnes PJ. 2004. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515-548.
2. Becker NDS, Kauczor HU. 2008. LUSI: The German component of the European trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie 31:320.
3. Belinsky SA. 2004. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707Y-717Y.
4. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE. 2002. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62:2370-2377.
5. Ben-Zaken Cohen S, Paré PD, Man SF, Sin DD. 2007. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: Examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 176:113-120.
6. Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A. Dépiscan Group. 2007. Baseline results of the depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR) Lung Cancer 58:50-58.
7. Böcking A, Biesterfeld S, Chatelain R, Gien-Gerlach G, Esser E. 1992. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alternative to routine cytology. Acta Cytol 36:37-47.
8. Brody JS, Spira A. 2006. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 3:535-537; Review.
9. Carpagnano GE, Foschino-Barbaro MP, Mulé G, Resta O, Tommasi S, Mangia A, Carpagnano F, Stea G, Susca A, Di Gioia G, De Lena M, Paradiso A. 2005. 3p Micro satellite alterations in exhaled breathe condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 172:738-744.
10. Celli BR. 2012. Chronic obstructive pulmonary disease and lung cancer: Common pathogenesis, shared clinical challenges. Proc Am Thorac Soc 9:74-79.
11. Chan HP, Lewis C, Thomas PS. 2009. Exhaled breath analysis: Novel approach for early detection of lung cancer. Lung Cancer 63:164-168.
12. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC, Robertson JF. 2008. Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax 63:228-233.
13. Church TR. National Lung Screening Trial Executive Committee. 2003. Chest radiography as the comparison for spiral CT in the national lung screening trial. Acad Radiol 10:713-715.
14. Colgan TJ, Patten SF, Jr., Lee JS. 1995. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory. Acta Cytol 39:1191-1198.
15. Cremona M, Calabrò E, Randi G, De Bortoli M, Mondellini P, Verri C, Sozzi G, Pierotti MA, La Vecchia C, Pastorino U, Bongarzone I. 2010. Elevated levels of the acutephase serum amyloid are associated with heightened lung cancer risk. Cancer 116:1326-1335.
16. D'Urso V, Collodoro A, Bagella L, Giordano A. 2010a. Cytometry and DNA ploidy: Clinical uses and molecular perspective. In Proceedings of the XXVII National Conference of Cytometry. Cytometry Part A 77 A:144-202; p195.
17. D'Urso V, Becciu F, Spada V, Doneddu V, Collodoro A, Giordano A, Pirina P, Bagella L. 2011. Preliminary study in early lung cancer detection using sputum sample. In Proceedings of the XXIX National Conference of Cytometry. Cytometry Part A 79 A:1028-1077; p1071.
18. de Costa D, Broodman I, Vanduijn MM, Stingl C, Dekker LJ, Burgers PC, Hoogsteden HC, Sillevis Smitt PA, van Klaveren RJ, Luider TM. 2010. Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry. J Proteome Res 9:2937-2945.
19. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. 2009. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: A combined mortality analysis from the Johns Hopkins lung project and the memorial Sloan-Kettering lung study. Cancer 115:5007-5017.
20. Duesberg P, Li R, Rasnick D. 2004. Aneuploidy approaching a perfect score in predicting and preventing cancer: Highlights from a conference held in Oakland, CA in January 2004. Cell Cycle 3:823-828.
21. D'Urso V, Collodoro A, Mattioli E, Giordano A, Bagella L. 2010b. Cytometry and DNA ploidy: Clinical uses and molecular perspective in gastric and lung cancer. J Cell Physiol 222:532-539.
22. Dziadziuszko R, Hirsch FR. 2008. Advances in genomic and proteomic studies of non-small-cell lung cancer: Clinical and translational research perspective. Clin Lung Cancer 9:78-84.
23. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. 1984. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the memorial Sloan-Kettering study. Am Rev Respir Dis 130:555-560.
24. Fong KM, Sekido Y, Gazdar AF, Minna JD. 2003. Lung cancer. 9: Molecular biology of lung cancer: Clinical implications. Thorax 58:890-892.
25. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, Uhlenhopp MA. 1984. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo clinic study. Am Rev Respir Dis 130:561-565.
26. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstralh EJ. 1991. Screening for lung cancer. A critique of the Mayo lung project. Cancer 67:1155-1164.
27. Frost JK, Ball WC, Jr., Levin ML, Tockman MS, Baker RR, Carter D, Eggleston JC, Erozan YS, Gupta PK, Khouri NF. 1984. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 130:549-554.
28. Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, Ruschpler P, Wirtz H. 2010. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 68:177-184.
29. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C. Lung Screening Study Research Group 2005. Final results of the lung screening study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47:9-15.
30. Greenberg AK, Lee MS. 2007. Biomarkers for lung cancer: Clinical uses. Curr Opin Pulm Med 13:249-255. Review.
31. Guzmán L, Depix MS, Salinas AM, Roldán R, Aguayo F, Silva A, Vinet R. 2012. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: A promising tool for early detection of COPD and lung cancer in smokers. Diagn Pathol 20:87.
32. Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ. 2008. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 31:133-139.
33. Han W, Wang T, Reilly AA, Keller SM, Spivack SD. 2009. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res 10:86.
34. International Early Lung Cancer Action Program Investigators Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS, 2006. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763-1771.
35. Herth FJ, Eberhardt R, Anantham D, Gompelmann D, Zakaria MW, Ernst A. 2009. Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection. J Thorac Oncol 4:1006-1015.
36. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G. DANTE Study Group. 2009. A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J Respir Crit Care Med 180:445-453.
37. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
38. Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA. 2009. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer 66:58-63.
39. Kasprzyk M, Dyszkiewicz W, Piwkowski C, Gasiorowski L, Kaczmarek E. 2006. Prognostic value of DNA ploidy: 5-Year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung. Lung Cancer 51:201-206.
40. Katz RL, Zaidi TM, Fernandez RL, Zhang J, He W, Acosta C, Daniely M, Madi L, Vargas MA, Dong Q, Gao X, Jiang F, Caraway NP, Vaporciyan AA, Roth JA, Spitz MR. 2008. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol 21:950-960. Erratum in: Mod Pathol. 2009 22(5):734-6. Mod Pathol. 2008 21(8):1065. Jiang, Xiaoying Gao Feng [corrected to Gao, Xiaoying]; Jiang, Feng [added].
41. Kemp R, Turic B, Eppler J, Garner DM. 2003. The role of the automated quantitative cytology sputum test in the early detection of lung cancer. Lung Cancer 41:S41.
42. Kemp RA, Reinders DM, Turic B. 2007. Detection of lung cancer by automated sputum cytometry. J Thorac Oncol 2:993-1000.
43. Kennedy TC, Proudfoot SP, Franklin WA, Merrick TA, Saccomanno G, Corkill ME, Mumma DL, Sirgi KE, Miller YE, Archer PG, Prochazka A. 1996. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 56:4673-4678.
44. Kennedy TC, McWilliams A, Edell E, Sutedja T, Downie G, Yung R, Gazdar A, Mathur PN. American College of Chest Physicians. 2007. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:221S-233S.
45. Kersting M, Friedl C, Kraus A, Behn M, Pankow W, Schuermann M. 2000. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 18:3221-3229.
46. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH. 2004. Tumor-specific methylation in bronchial lavage for the early detection of non-small cell lung cancer. J Clin Oncol 22:2363-2370.
47. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, Chaturvedi AK, Wacholder S, Landi MT, Lubin JH, Caporaso NE. 2009. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS ONE 4:e7380.
48. Kubik A, Polak J. 1986. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 57:2427-2437.
49. Kubik AK, Parkin DM, Zatloukal P. 2000. Czech study on lung cancer screening: Post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 89:2363-2368.
50. Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF. 2011. Early CDT-Lung: An immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4:1126-1134.
51. Lewis PD, Lewis KE, Ghosal R, Bayliss S, Lloyd AJ, Wills J, Godfrey R, Kloer P, Mur LA. 2010. Evaluation of FTIR spectroscopy as a diagnostic tool for lung cancer using sputum. BMC Cancer 10:640.
52. Li R, Todd NW, Qiu Q, Fan T, Zhao RY, Rodgers WH, Fang HB, Katz RL, Stass SA, Jiang F. 2007. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 13:482-487.
53. Li G, Guillaud M, LeRiche J, McWilliams A, Gazdar A, Lam S, MacAulay C. 2012. Automated sputum cytometry for detection of intraepithelial neoplasias in the lung. Anal Cell Pathol (Amst) 35:187-201.
54. Liu Y, Lan Q, Shen M, Jin J, Mumford J, Ren D, Keohavong P. 2008. Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions. Anticancer Res 28:2061-2066.
55. Loganathan RS, Stover DE, Shi W, Venkatraman E. 2006. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 129:1305-1312.
56. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, Spinelli C, Falaschi F, Grazzini M, Innocenti F, Ronchi C, Paci E, ITALUNG Study Research Group. 2009. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64:34-40.
57. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. 2006. Extended lung cancer incidence follow-up in the Mayo lung project and overdiagnosis. J Natl Cancer Inst 98:748-756.
58. Marek W, Richartz G, Philippou S, Marek L, Kotschy-Lang N. 2007. Sputum screening for lung cancer in radon exposed uranium miners: A comparison of semi-automated sputum cytometry and conventional cytology. J Physiol Pharmacol 58:349-361.
59. Minna JD, Fong K, Zöchbauer-Müller S, Gazdar AF. 2002. Molecular pathogenesis of lung cancer and potential translational applications. Cancer J 8:S41-S46.
60. Neumann T, Meyer M, Patten FW, Johnson FL, Erozan YS, Frable WJ, Gupta PK, Zaman MB, Nelson AC. 2009. Premalignant and malignant cells in sputum from lung cancer patients. Cancer 117:473-481.
61. National Lung Program, Memorial Sloan-Kettering Cancer Center. 1984. Final Report and Data Summary. Bethesda: National Cancer Institute.
62. Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D. 2010. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylationspecific PCR. Clin Cancer Res 16:3463-3472.
63. Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri LM. 2004. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 59:679-681.
64. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, Thorsen H, Brodersen J, Skov BG, Døssing M, Mortensen J, Richter K, Clementsen P, Seersholm N. 2009. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 4:608-614.
65. Qiu Q, Todd NW, Li R, Peng H, Liu Z, Yfantis HG, Katz RL, Stass SA, Jiang F. 2008. Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. Cancer (Cancer Cytopathol) 114:275-283.
66. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. 2009. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 10:42-46.
67. Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J. 2010. Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 33:E124.
68. Saccomanno G, Saunders RP, Ellis H, Archer VE, Wood BG, Becler PA. 1963. Concentration of carcinoma or atypical cells in sputum. Acta Cytol 7:305-310.
69. Schottenfeld D, Beebe-Dimmer J. 2006. Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56:69-83; Review.
70. Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF. 2007. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 247:56-71.
71. Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Lo Vullo S, Verri C, Pastorino U. 2009. Plasma DNA quantification in lung cancer computed tomography screening: Five-year results of a prospective study. Am J Respir Crit Care Med 179:69-74.
72. Suga Y, Miyajima K, Oikawa T, Maeda J, Usuda J, Kajiwara N, Ohira T, Uchida O, Tsuboi M, Hirano T, Kato H, Ikeda N. 2008. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer. Oncol Rep 20:1137-1142.
73. Sutedja G. 2003. New techniques for early detection of lung cancer. Eur Respir J 21:57S-66S.
74. Suzuki M, Yoshino I. 2010. Aberrant methylation in non-small cell lung cancer. Surg Today 40:602-607; Review.
75. Tockman MS. 1986. Survival and mortality from lung cancer in a screened population: The Johns Hopkins study. Chest 89:324S-325S.
76. Tomida M, Mikami I, Takeuchi S, Nishimura H, Akiyama H. 2009. Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol 135:1223-1229.
77. Travis WD, Travis LB, Devesa SS. 1995. Lung cancer. Cancer 75:191-202.
78. Troni GM, Cariaggi MP, Bulgaresi P, Houssami N, Ciatto S. 2007. Reliability of sparing Papanicolaou test conventional reading in cases reported as no further review at AutoPap-assisted cytological screening: Survey of 30, 658 cases with follow-up cytological screening. Cancer (Cancer Cytopathol) 111:93-98.
79. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. 2007. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285-290.
80. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, van Iersel CA, van den Bergh KA, van't Westeinde S, van der Aalst C, Thunnissen E, Xu DM, Wang Y, Zhao Y, Gietema HA, de Hoop BJ, Groen HJ, de Bock GH, van Ooijen P, Weenink C, Verschakelen J, Lammers JW, Timens W, Willebrand D, Vink A, Mali W, de Koning HJ. 2009. Management of lung nodules detected by volume CT scanning. N Engl J Med 361:2221-2229.
81. Van't Westeinde SC, van Klaveren RJ. 2011. Screening and early detection of lung cancer. Cancer J 17:3-10.
82. Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, Yin X, Hirsch FR, Kennedy TC, Keith RL, Barón AE, Belinsky SA, Miller YE, Byers T, Franklin WA. 2010. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) 3:447-453.
83. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. 2008. Smoking and lung cancer: The role of inflammation. Proc Am Thorac Soc 5:811-815.
84. Xie GS, Hou AR, Li LY, Gao YN, Cheng SJ. 2006. Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer. Chin Med J (Engl) 119:1469-1472.
85. Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. 2010. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67:170-176.
86. Xing S, Khanavkar B, Nakhosteen JA, Atay Z, Jöckel KH, Marek W, RIDTELC Lung Study Group. 2005. Predictive value of image cytometry for diagnosis of lung cancer in heavy smokers. Eur Respir J 25:956-963.
87. Xing L, Todd NW, Yu L, Fang H, Jiang F. 2010. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 23:1157-1164.
88. Yoon KA, Park S, Lee SH, Kim JH, Lee JS. 2009. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn 11:182-185.
89. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC. 2008. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48-57.
90. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F. 2010. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 127:2870-2878.
91. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. 2001. Aberrant promoter methylation of multiple genes in nonsmall cell lung cancers. Cancer Res 61:249-255.